BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferraino KE, Cora N, Pollard CM, Sizova A, Maning J, Lymperopoulos A. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression. Cell Signal 2021;82:109967. [PMID: 33640432 DOI: 10.1016/j.cellsig.2021.109967] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Hsiao W, Hsin K, Wu Z, Song J, Yeh Y, Chen Y, Tsai C, Chen P, Shia K, Chang C, Hung M. Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.106236] [Reference Citation Analysis]
2 Ichiki T, Jinno A, Tsuji Y. Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States. Biology 2022;11:859. [DOI: 10.3390/biology11060859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mogi M. Aldosterone breakthrough from a pharmacological perspective. Hypertens Res 2022. [PMID: 35422512 DOI: 10.1038/s41440-022-00913-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ma K, Gao W, Xu H, Liang W, Ma G, Anand V. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-8. [DOI: 10.1155/2022/3239057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lino CA, Barreto-chaves ML. Beta-arrestins in the context of cardiovascular diseases: Focusing on type 1 angiotensin II receptor (AT1R). Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sarkar K, Joedicke L, Westwood M, Burnley R, Wright M, Mcmillan D, Byrne B. Modulation of PTH1R signaling by an extracellular binding antibody. Vitamins and Hormones 2022. [DOI: 10.1016/bs.vh.2022.04.002] [Reference Citation Analysis]
7 Lymperopoulos A, Borges JI. Arrestins in cardiac function. Arrestins 2022. [DOI: 10.1016/b978-0-323-85756-7.00008-x] [Reference Citation Analysis]
8 Lymperopoulos A, Borges JI, Carbone AM, Cora N, Sizova A. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling. Pharmacol Res 2021;174:105943. [PMID: 34662735 DOI: 10.1016/j.phrs.2021.105943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Tamura K, Azushima K, Kinguchi S, Wakui H, Yamaji T. ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond. Hypertens Res 2021. [PMID: 34642449 DOI: 10.1038/s41440-021-00776-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Verma K, Pant M, Paliwal S, Dwivedi J, Sharma S. An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update. Front Pharmacol 2021;12:734917. [PMID: 34489714 DOI: 10.3389/fphar.2021.734917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
11 Turu G, Soltész-Katona E, Tóth AD, Juhász C, Cserző M, Misák Á, Balla A, Caron MG, Hunyady L. Biased Coupling to β-Arrestin of Two Common Variants of the CB2 Cannabinoid Receptor. Front Endocrinol (Lausanne) 2021;12:714561. [PMID: 34484125 DOI: 10.3389/fendo.2021.714561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Guitart-Mampel M, Urquiza P, Borges JI, Lymperopoulos A, Solesio ME. Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function. Cells 2021;10:1552. [PMID: 34205363 DOI: 10.3390/cells10061552] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
13 Rakib A, Eva TA, Sami SA, Mitra S, Nafiz IH, Das A, Tareq AM, Nainu F, Dhama K, Emran TB, Simal-Gandara J. Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review. Pharmaceutics 2021;13:838. [PMID: 34198801 DOI: 10.3390/pharmaceutics13060838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Nagi K, Onaran HO. Biased agonism at G protein-coupled receptors. Cell Signal 2021;83:109981. [PMID: 33744417 DOI: 10.1016/j.cellsig.2021.109981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]